← Back to Search

Crisis Prevention Program for Autism

N/A
Waitlist Available
Led By Luther Kalb, PhD
Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a child with autism
The child must have some behavioral concerns (e.g., aggression, property destruction, elopement, tantrums), as listed on section 2 of the MCAS-R.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, 8 weeks
Awards & highlights

Study Summary

This trial will evaluate a crisis prevention program for autistic children who are at risk for mental health crises, which can cause harm to self or others.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism
  • Behavioral Problem

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have a child who has been diagnosed with autism.
Select...
The child must exhibit certain behaviors like aggression, breaking things, running away, or throwing tantrums as noted in section 2 of the MCAS-R.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in The Crisis Prevention Index scores
Secondary outcome measures
Change in Aberrant Behavior Checklist scores
Change in Me as a Parent Scale scores
Change in Mental Health Crisis Assessment Scale-Revised scores

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Crisis Prevention ArmActive Control1 Intervention
Group II: ControlPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
88 Previous Clinical Trials
24,907 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
3,418 Patients Enrolled for Autism Spectrum Disorder
Luther Kalb, PhDPrincipal InvestigatorHugo W. Moser Research Institute at Kennedy Krieger, Inc.

Media Library

Crisis Prevention Program Clinical Trial Eligibility Overview. Trial Name: NCT05681143 — N/A
Autism Spectrum Disorder Research Study Groups: Crisis Prevention Arm, Control
Autism Spectrum Disorder Clinical Trial 2023: Crisis Prevention Program Highlights & Side Effects. Trial Name: NCT05681143 — N/A
Crisis Prevention Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05681143 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limitation for participating in this experiment?

"Patients aged between 3 years and 17 years are eligible for this medical trial."

Answered by AI

Is there any space available for potential participants in this investigation?

"As per the clinicaltrials.gov platform, this medical trial is not presently enrolling patients as it was initially posted on 2nd January 2023 and recently edited on 9th January 2023. However, there are 352 other trials that remain open for recruitment."

Answered by AI

Am I eligible to sign up for participation in this clinical trial?

"This autism-focused trial is recruiting 50 participants aged 3 to 17, with the prerequisite that their caregivers have a Crisis Prevention Index score of 13 or less. Additionally, section 2 of the MCAS-R must list behavioural issues such as aggression, property destruction and elopement; an Acuity score can be no higher than 19; and medical/mental health care must have been received in the last six months."

Answered by AI
~29 spots leftby Mar 2025